Showing 851-860 of 2371 results for "".
Bruton Tyrosine Kinase Inhibition in Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/bruton-tyrosine-kinase-inhibition-in-multiple-sclerosis/31872/The missing link for treatment optimization?Multiple Sclerosis in the Hispanic/Latinx Population
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/multiple-sclerosis-in-the-hispaniclatinx-population/31757/Hispanic/Latinx individuals with MS are a diverse group for whom genetic and environmental factors affect prevalence, disease course, and treatment that varies by region.Sports Concussion and the Clinical Neurologist, Part I
https://practicalneurology.com/diseases-diagnoses/tbi/sports-concussion-and-the-clinical-neurologist-part-i/30796/Neurologists, who increasingly will confront patients diagnosed with sports concussion, must be adept at identifying and managing the condition. Part I of a series reviews epidemiology, definition, mechanism, and clinical manifestations.- Epilepsy Essentialshttps://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/PN1005epilepsy-pdf/31388/Exploring the Complex Interplay Between Epilepsy and Mood DisordersEpilepsy and depression frequently coexist as comorbid conditions, significantly impacting patients' quality of life. Comorbidity, defined as the simultaneous occurrence of two or more diseases, does not necessarily indicate causalit
Health Care Disparities in Alzheimer Disease Diagnosis and the Use of Amyloid-Targeting Treatments
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/health-care-disparities-in-alzheimer-disease-diagnosis-and-the-use-of-amyloid-targeting-treatments/36240/Disparities in Alzheimer disease care persist, and people from underrepresented racial, ethnic, or socioeconomic groups face considerable barriers to early diagnosis and access to disease-modifying anti-amyloid therapies.The Myth of Medical Gaslighting: When Patient Perception and Physician Intention Collide
https://practicalneurology.com/columns/practice-management/the-myth-of-medical-gaslighting-when-patient-perception-and-physician-intention-collide/36117/Open and frank communication with patients, especially those considered challenging, has a dual benefit: minimizing errors and improving patient trust.Special Report: Inside the AED Development Process
https://practicalneurology.com/columns/practice-management/special-report-inside-the-aed-development-process/30845/- Epilepsy Essentialshttps://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/PN0708Epilepsy-pdf/31003/Complementary and Alternative Medical Therapies (CAMs) are increasingly utilized by patients with epilepsy, highlighting the necessity for healthcare professionals to be vigilant about their potential impacts. CAMs encompass a variety of treatments, including herbal medicines, dietary supplements, a
- Movement Disorders Focushttps://practicalneurology.com/diseases-diagnoses/movement-disorders/pn0607-movementdisorder-pdf/31164/Sydenham’s Chorea in Adolescents: Clinical Presentation and ManagementSydenham’s chorea is a critical movement disorder in adolescents, often emerging as a delayed neurological complication of acute rheumatic fever (ARF) following a Group A streptococcal infection. While clinicians might first consi
- News Briefshttps://practicalneurology.com/columns/practice-management/news-briefs/31191/Advancements in Neurology: Key Developments in Epilepsy Management and BeyondRecent breakthroughs in epilepsy care are equipping neurologists with enhanced therapeutic options and optimizing existing treatments. A pivotal study published in the April 10th issue of *Neurology* highlights the efficacy